Colgate director granted shares and stock options
COLGATE PALMOLIVE CO director John P. Bilbrey reported routine equity compensation and updated holdings.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO director John P. Bilbrey reported routine equity compensation and updated holdings. He received a grant of 2,075 shares of Common Stock as an annual director stock grant under the issuer's incentive compensation plan, increasing his direct holdings to 39,820 shares. He also received an annual director stock option grant for 2,424 shares at an exercise price of $86.74 per share, expiring on May 11, 2034, which becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date. In addition, a separate entry reflects 4,719 shares of Common Stock held indirectly by a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,499 shares
Grant/Award
3 txns
Insider
BILBREY JOHN P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,424 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 2,075 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,424 contracts (Direct);
Common Stock — 39,820 shares (Direct);
Common Stock — 4,719 shares (Indirect, By Trust)
Footnotes (3)
- F1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
- F2. Annual director stock option grant under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Key Figures
Director stock grant: 2,075 shares
Options granted: 2,424 options
Option exercise price: $86.74 per share
+3 more
6 metrics
Director stock grant
2,075 shares
Annual director stock grant of Common Stock
Options granted
2,424 options
Annual director stock option grant
Option exercise price
$86.74 per share
Stock option (Right to Buy) strike price
Option expiration
May 11, 2034
Expiration date of stock options
Direct holdings after grant
39,820 shares
Common Stock held directly following grant
Indirect trust holdings
4,719 shares
Common Stock held indirectly by trust
Key Terms
Annual director stock grant, stock option, incentive compensation plan, stock unit account, +1 more
5 terms
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
stock option financial
"Annual director stock option grant under the issuer's incentive compensation plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CL director John P. Bilbrey report in this Form 4 filing?
John P. Bilbrey reported routine equity compensation awards. He received 2,075 shares of Common Stock as an annual director stock grant and 2,424 stock options, plus reported 4,719 shares held indirectly by a trust.
What are the key terms of John P. Bilbrey’s new Colgate-Palmolive stock options?
He received stock options covering 2,424 shares of Common Stock at an exercise price of $86.74. The options expire on May 11, 2034 and vest in equal annual installments over three years starting on May 11, 2027.
Are John P. Bilbrey’s latest Colgate-Palmolive (CL) transactions open-market buys or sales?
No, the transactions are grants, not open-market trades. The Form 4 shows an annual director stock grant of 2,075 shares and an annual director stock option grant for 2,424 shares under the company’s incentive compensation plan.
How do John P. Bilbrey’s Colgate-Palmolive stock options vest over time?
The options become exercisable in three equal annual installments. Vesting begins on the first anniversary of the May 11, 2026 grant date and continues annually for a total three-year vesting schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
